Source: Annual Congress 2012 - Optimising outcomes after lung transplantation
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
J. Wojarski, S. Zeglen, M. Ochman, W. Karolak, M. Zembala (Zabrze, Poland). Early sirolimus immunosuppression is safe in lung transplantation. Eur Respir J 2012; 40: Suppl. 56, 2440

Member's Comments

No comment yet.

Related content which might interest you: Aerosolized liposomal cyclosporine A for treatment of progressive allograft dysfunction following lung transplantation Source: Annual Congress 2013 –Clinical studies in lung transplantation Year: 2013 Azathioprine discontinuation and medium and long term outcomes after lung transplantation Source: International Congress 2015 – Outcomes of lung transplantation Year: 2015 Dichotomy in pulmonary graft-versus-host disease evident among allogeneic stem-cell transplant recipients undergoing lung transplantation Source: Eur Respir J 2016; 48: 1807-1810 Year: 2016 Efficacy of tacrolimus rescue therapy in refractory acute rejection (AR) after lung transplantation Source: Eur Respir J 2001; 18: Suppl. 33, 298s Year: 2001 Evaluation of early conversion to prolonged-release tacrolimus in lung transplantation. Source: International Congress 2018 – Moving lung transplantation forward Year: 2018 Immunosuppressive therapy after human lung transplantation Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=105 Year: 2003 Negative consequences of immunosuppressive therapy on bronchial healing following lung transplantation (LTx) Source: Annual Congress 2013 –Clinical studies in lung transplantation Year: 2013 Treatment options in chronic GVHD and CLAD post lung transplantation Source: International Congress 2016 – Chronic graft-versus-host disease and chronic allograft dysfunction after lung transplantation: similarities and dissimilarities Year: 2016 Immunosuppressive therapy after human lung transplantation Source: Eur Respir J 2004; 23: 159-171 Year: 2004 Lung transplantation Source: Respipedia Article Year: 2019 Tacrolimus versus cyclosporine for lung transplant recipients in Portugal Source: Virtual Congress 2020 – Clinical management of lung transplant recipients Year: 2020 Infectious complications after lung transplantation Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=193 Year: 2003 Long-term kinetics of CD19+CD24highCD38highBreg cells in lung transplant recipients Source: International Congress 2016 – Lung allograft dysfunction: insights into inflammatory/immune mechanisms Year: 2016 Preemptive therapy for systemic and pulmonary human cytomegalovirus infection in lung transplant recipients Source: Annual Congress 2009 - Lung transplantation: pre- and postoperative problems Year: 2009 NFkB location in T-cells is promising to monitor immunosuppression after lung transplantation Source: International Congress 2014 – Post-transplant complications: from pathogenesis to treatment Year: 2014 Mycophenolate mofetil reduces alveolar inflammation and acute rejection and improves overall outcome after lung transplantation Source: Eur Respir J 2006; 28: Suppl. 50, 724s Year: 2006 The influence of different immunosuppressive regimen on non-mnestic cognitive functions in patients after lung transplantation Source: International Congress 2014 – Maximise lung transplant outcomes: pre- and post-operative issues Year: 2014 Is gammaglobuline anti-CMV warranted in lung transplantation? Source: Eur Respir J 2005; 26: Suppl. 49, 636s Year: 2005 Azithromycin treatment in patients with BOS after lung transplantation Source: ISSN=ISSN 1810-6838, ISBN=, page=178 Year: 2005